Semaglutide
1.22M
Volume
+4900%
Growth
exploding
About the Topic
Medication used for the treatment of type 2 diabetes and long-term weight management. It belongs to the class of glucagon-like peptide-1 (GLP-1) receptor agonists, which mimic the GLP-1 hormone to regulate blood sugar levels and appetite. This medication is primarily targeted at individuals with type 2 diabetes or those seeking medical assistance for weight management.
Semaglutide was discovered on May 23rd 2023 and it currently has a search volume of 1.22M with a growth of +4900%.
Key Indicators
Growth
- Exploding
- Regular
- Peaked
Speed
- Exponential
- Constant
- Stationary
Seasonality
- High
- Medium
- Low
Volatility
- High
- Average
- Low
Members Only
Try Exploding Topics Pro
Get Free, Unlimited Access for 7 Days.
Categories
Save this topic and build your own trend dashboard.
Available with Exploding Topics Pro, try it now.
1.1M+ trends in our growing database.